Li Pan, Y Yuanyuan, Cai Hao, Zhang Huihong, Zhou Yuying
Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.
Department of Neurology, Tianjin Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin Huanhu Hospital Affiliated to Nankai University, Tianjin University Huanhu Hospital, Tianjin, China.
Front Neurol. 2022 Nov 3;13:993399. doi: 10.3389/fneur.2022.993399. eCollection 2022.
TANK1-binding kinase 1 (TBK1) is mainly involved in the regulation of various cellular pathways through the autophagic lysosomal system, and the loss of function or hypofunction caused by TBK1 gene mutation mainly leads to frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS), and ALS-FTLD. Alzheimer's disease (AD) due to TBK1 gene mutation is extremely rare, and only one case has been reported in China so far. In this report, we described a patient with early-onset AD (EOAD) in whom a new probable pathogenic variant c.704A>T (p.Tyr235Phe) in the TBK1 gene was identified by a whole-genome sequencing analysis. It is suggested that FTLD gene mutation may exist in patients with clinical manifestations of AD.
TANK1结合激酶1(TBK1)主要通过自噬溶酶体系统参与多种细胞途径的调节,TBK1基因突变导致的功能丧失或功能减退主要引发额颞叶痴呆(FTLD)、肌萎缩侧索硬化症(ALS)以及ALS-FTLD。由TBK1基因突变引起的阿尔茨海默病(AD)极为罕见,迄今为止中国仅报道过一例。在本报告中,我们描述了一名早发性AD(EOAD)患者,通过全基因组测序分析在其体内鉴定出一种新的可能致病变异c.704A>T(p.Tyr235Phe)。提示具有AD临床表现的患者可能存在FTLD基因突变。